{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:47:31Z","timestamp":1789523251465,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.virol.2023.01.016","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T08:30:56Z","timestamp":1675153856000},"page":"10-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Development of novel antiviral peptides against dengue serotypes 1-4"],"prefix":"10.1016","volume":"580","author":[{"given":"Michelle Felicia","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Ishtiaq","family":"Anasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chit Laa","family":"Poh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virol.2023.01.016_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12985-017-0895-1","article-title":"Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication","volume":"14","author":"Abdul Ahmad","year":"2017","journal-title":"Virol. J."},{"issue":"6","key":"10.1016\/j.virol.2023.01.016_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7150\/ijms.5037","article-title":"Inhibition of dengue virus entry into target cells using synthetic antiviral peptides","volume":"10","author":"Alhoot","year":"2013","journal-title":"Int. J. Med. Sci."},{"issue":"7446","key":"10.1016\/j.virol.2023.01.016_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virol.2023.01.016_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annu. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.virol.2023.01.016_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/anie.201205674","article-title":"N-methylation of peptides and proteins: an important element for modulating biological functions","volume":"52","author":"Chatterjee","year":"2013","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"10","key":"10.1016\/j.virol.2023.01.016_bib8","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1021\/acschembio.6b00404","article-title":"Backbone modification of a parathyroid hormone receptor-1 antagonist\/inverse agonist","volume":"11","author":"Cheloha","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"46","key":"10.1016\/j.virol.2023.01.016_bib9","doi-asserted-by":"crossref","first-page":"18662","DOI":"10.1073\/pnas.1310962110","article-title":"Atomic-level functional model of dengue virus Envelope protein infectivity","volume":"110","author":"Christian","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.virol.2023.01.016_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000721","article-title":"Structural optimization and de novo design of dengue virus entry inhibitory peptides","volume":"4","author":"Costin","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2023.01.016_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.antiviral.2018.04.018","article-title":"Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with \u03b23 integrin","volume":"155","author":"Cui","year":"2018","journal-title":"Antivir. Res."},{"issue":"8","key":"10.1016\/j.virol.2023.01.016_bib13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.chembiol.2018.05.011","article-title":"Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein","volume":"25","author":"de Wispelaere","year":"2018","journal-title":"Cell Chem Biol"},{"issue":"10","key":"10.1016\/j.virol.2023.01.016_bib14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40262-013-0079-0","article-title":"Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides","volume":"52","author":"Diao","year":"2013","journal-title":"Clin. Pharmacokinet."},{"issue":"22","key":"10.1016\/j.virol.2023.01.016_bib15","doi-asserted-by":"crossref","first-page":"10098","DOI":"10.1021\/acs.jmedchem.9b00456","article-title":"Enhancing the cell permeability of stapled peptides with a cyclic cell-penetrating peptide","volume":"62","author":"Dougherty","year":"2019","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.virol.2023.01.016_bib16","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1128\/jvi.69.11.7232-7243.1995","article-title":"Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum","volume":"69","author":"Falgout","year":"1995","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2023.01.016_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.virol.2007.05.042","article-title":"Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus","volume":"366","author":"Gromowski","year":"2007","journal-title":"Virology"},{"issue":"9966","key":"10.1016\/j.virol.2023.01.016_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2023.01.016_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2022.100932","article-title":"Seawater fungi-derived compound screening to identify novel small molecules against dengue virus NS5 methyltransferase and NS2B\/NS3 protease","volume":"30","author":"Hasan","year":"2022","journal-title":"Inform. Med. Unlocked"},{"key":"10.1016\/j.virol.2023.01.016_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1743-422X-2-49","article-title":"Peptide inhibitors of dengue virus and West Nile virus infectivity","volume":"2","author":"Hrobowski","year":"2005","journal-title":"Virol. J."},{"issue":"2","key":"10.1016\/j.virol.2023.01.016_bib59","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.virol.2009.10.027","article-title":"The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion","volume":"396","author":"Huang","year":"2010","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2023.01.016_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/v13010058","article-title":"Inhibition of enterovirus A71 by a novel 2-phenyl-benzimidazole derivative","volume":"13","author":"Ibba","year":"2021","journal-title":"Viruses"},{"issue":"13","key":"10.1016\/j.virol.2023.01.016_bib60","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1128\/JVI.00197-13","article-title":"Immature and mature dengue serotype 1 virus structures provide insight into the maturation process","volume":"87","author":"Kostyuchenko","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.01.016_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08347","article-title":"The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus","volume":"4","author":"Kraemer","year":"2015","journal-title":"Elife"},{"issue":"16","key":"10.1016\/j.virol.2023.01.016_bib23","doi-asserted-by":"crossref","first-page":"8757","DOI":"10.3390\/ijms22168757","article-title":"Functional insights into silymarin as an antiviral agent against enterovirus A71 (EV-A71)","volume":"22","author":"Lalani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.virol.2023.01.016_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14787210.2017.1248405","article-title":"Current management of severe dengue infection","volume":"15","author":"Lee","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.virol.2023.01.016_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","article-title":"Dengue drug discovery: progress, challenges and outlook","volume":"163","author":"Lim","year":"2019","journal-title":"Antivir. Res."},{"issue":"11","key":"10.1016\/j.virol.2023.01.016_bib26","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/cbic.201000717","article-title":"Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics","volume":"12","author":"Liskamp","year":"2011","journal-title":"Chembiochem"},{"issue":"11","key":"10.1016\/j.virol.2023.01.016_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050995","article-title":"Release of dengue virus genome induced by a peptide inhibitor","volume":"7","author":"Lok","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.virol.2023.01.016_bib28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","article-title":"Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"14","author":"Low","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"10.1016\/j.virol.2023.01.016_bib29","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3851\/IMP1884","article-title":"Narasin, a novel antiviral compound that blocks dengue virus protein expression","volume":"16","author":"Low","year":"2011","journal-title":"Antivir. Ther."},{"issue":"1","key":"10.1016\/j.virol.2023.01.016_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98949-y","article-title":"Antiviral activity of silymarin and baicalein against dengue virus","volume":"11","author":"Low","year":"2021","journal-title":"Sci. Rep."},{"issue":"2\u20133","key":"10.1016\/j.virol.2023.01.016_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i23.30","article-title":"Emerging trends in oral delivery of peptide and protein drugs","volume":"20","author":"Mahato","year":"2003","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"3","key":"10.1016\/j.virol.2023.01.016_bib32","article-title":"Neglected tropical diseases: epidemiology and global burden","volume":"2","author":"Mitra","year":"2017","journal-title":"Trav. Med. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virol.2023.01.016_bib33","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.virol.2023.01.016_bib34","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/JVI.79.2.1223-1231.2005","article-title":"Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein","volume":"79","author":"Modis","year":"2005","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.virol.2023.01.016_bib61","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1128\/JVI.00116-07","article-title":"Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation","volume":"81","author":"Mondotte","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.01.016_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2017.11.009","article-title":"The antimicrobial peptide HS-1 inhibits dengue virus infection","volume":"514","author":"Monteiro","year":"2018","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2023.01.016_bib36","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients","volume":"207","author":"Nguyen","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virol.2023.01.016_bib38","article-title":"Current trends and limitations in dengue antiviral research","volume":"6","author":"Obi","year":"2021","journal-title":"Trav. Med. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2023.01.016_bib39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cbdd.12309","article-title":"Peptide inhibitors against dengue virus infection","volume":"84","author":"Panya","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"issue":"11","key":"10.1016\/j.virol.2023.01.016_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/v12111267","article-title":"A synthetic bioactive peptide derived from the Asian medicinal plant","volume":"12","author":"Panya","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.virol.2023.01.016_bib62","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2005.11.042","article-title":"Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN","volume":"124","author":"Pokidysheva","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.virol.2023.01.016_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170797","article-title":"PD1 CD44 antiviral peptide as an inhibitor of the protein-protein interaction in dengue virus invasion","volume":"153","author":"Recalde-Reyes","year":"2022","journal-title":"Peptides"},{"issue":"13","key":"10.1016\/j.virol.2023.01.016_bib41","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1002\/anie.201916257","article-title":"Multicomponent peptide stapling as a diversity-driven tool for the development of inhibitors of protein-protein interactions","volume":"59","author":"Ricardo","year":"2020","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"2","key":"10.1016\/j.virol.2023.01.016_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.virol.2013.03.011","article-title":"Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion","volume":"441","author":"Roehrig","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.01.016_bib43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2334-12-314","article-title":"Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1","volume":"12","author":"Rothan","year":"2012","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.virol.2023.01.016_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030653","article-title":"Phytochemical compound screening to identify novel small molecules against dengue virus: a docking and dynamics study","volume":"27","author":"Shimu","year":"2022","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.virol.2023.01.016_bib45","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1128\/JVI.00432-07","article-title":"Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes","volume":"81","author":"Sukupolvi-Petty","year":"2007","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2023.01.016_bib46","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial","volume":"55","author":"Tam","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.virol.2023.01.016_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034589","article-title":"Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1","volume":"7","author":"Tan","year":"2012","journal-title":"PLoS One"},{"issue":"Pt 8","key":"10.1016\/j.virol.2023.01.016_bib47","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1099\/0022-1317-82-8-1885","article-title":"Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism","volume":"82","author":"Thullier","year":"2001","journal-title":"J. Gen. Virol."},{"issue":"21","key":"10.1016\/j.virol.2023.01.016_bib48","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/cbic.201700352","article-title":"Effect of stapling architecture on physiochemical properties and cell permeability of stapled \u03b1-helical peptides: a comparative study","volume":"18","author":"Tian","year":"2017","journal-title":"Chembiochem"},{"issue":"8","key":"10.1016\/j.virol.2023.01.016_bib49","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"7","key":"10.1016\/j.virol.2023.01.016_bib50","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1128\/JVI.06871-11","article-title":"Recombinant dengue type 2 viruses with altered e protein domain III epitopes are efficiently neutralized by human immune sera","volume":"86","author":"Wahala","year":"2012","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2023.01.016_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"9","key":"10.1016\/j.virol.2023.01.016_bib52","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1128\/AAC.00620-11","article-title":"A translation inhibitor that suppresses dengue virus in vitro and in vivo","volume":"55","author":"Wang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.virol.2023.01.016_bib53","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/cbic.201500312","article-title":"Peptide backbone composition and protease susceptibility: impact of modification type, position, and tandem substitution","volume":"17","author":"Werner","year":"2016","journal-title":"Chembiochem"},{"issue":"10169","key":"10.1016\/j.virol.2023.01.016_bib54","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","article-title":"Dengue","volume":"393","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.virol.2023.01.016_bib55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1586\/14760584.2016.1154459","article-title":"Edging closer towards the goal of a dengue vaccine","volume":"15","author":"Wilder-Smith","year":"2016","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.virol.2023.01.016_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-\u00c5 resolution","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"10","key":"10.1016\/j.virol.2023.01.016_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001157","article-title":"In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions","volume":"6","author":"Zheng","year":"2010","journal-title":"PLoS Pathog."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:57:14Z","timestamp":1758589034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682223000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":59,"alternative-id":["S0042682223000223"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2023.01.016","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel antiviral peptides against dengue serotypes 1-4","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2023.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}